Search Results - "Krisl, Jill C."
-
1
Gastrointestinal Bleeding in Left Ventricular Assist Device: Octreotide and Other Treatment Modalities
Published in ASAIO journal (1992) (01-07-2018)“…Left ventricular assist devices (LVADs) offer a therapeutic strategy for patients with end-stage heart failure. Increased device utilization has also increased…”
Get full text
Journal Article -
2
Leflunomide Efficacy and Pharmacodynamics for the Treatment of BK Viral Infection
Published in Clinical journal of the American Society of Nephrology (01-06-2012)“…BK virus is an infection in kidney transplantation patients jeopardizing graft survival. Unfortunately, there is no consensus on treatment of BK viremia and…”
Get full text
Journal Article -
3
Terbutaline for Management of Relative Bradycardia Post‐Orthotopic Heart Transplant: A Single Center Experience
Published in Clinical transplantation (01-11-2024)“…ABSTRACT Background Vagal nerve denervation during the heart transplant procedure results in higher resting heart rates in these recipients compared to the…”
Get full text
Journal Article -
4
Role of thromboelastography in predicting and defining pump thrombosis in left ventricular assist device patients
Published in Thrombosis research (01-08-2020)“…Optimal anticoagulation for left ventricular assist device recipients aims to balance thrombosis and bleeding complications. Routine plasma-based coagulation…”
Get full text
Journal Article -
5
Effectiveness of combined plasma cell therapy and costimulation blockade based desensitization regimen in heart transplant candidates
Published in Clinical transplantation (01-02-2024)“…Background Desensitization is one of the strategies to reduce antibodies and facilitate heart transplantation in highly sensitized patients. We describe our…”
Get full text
Journal Article -
6
Acute Rejection Clinically Defined Phenotypes Correlate With Long-term Renal Allograft Survival
Published in Transplantation (01-10-2015)“…BACKGROUNDClassification of acute rejection (AR) based on etiology and timing may provide a means for enhancing therapeutic results and allograft survival…”
Get full text
Journal Article -
7
A Case-Based Approach to the Practical Application of Dexmedetomidine in Critically Ill Adults
Published in Pharmacotherapy (01-02-2013)“…Dexmedetomidine is a selective α2‐adrenoceptor agonist that offers unique sedation because patients are readily awakened while administration continues and the…”
Get full text
Journal Article -
8
Clinical Usefulness of Recombinant Activated Factor VII in Patients with Liver Failure Undergoing Invasive Procedures
Published in The Annals of pharmacotherapy (01-11-2011)“…Objective: To evaluate the use of recombinant activated factor VII (rFVIIa) in patients with liver failure undergoing invasive procedures. Methods: An…”
Get full text
Journal Article -
9
Bortezomib-Based Antibody-Mediated Rejection Therapy and Simultaneous Conversion to Belatacept
Published in Transplantation (27-02-2014)Get full text
Journal Article -
10
The Use of Activated Recombinant Factor VII in a Patient with Fulminant Hepatic Failure Requiring Placement of an Intracranial Pressure Monitor
Published in The Annals of pharmacotherapy (01-11-2011)“…Objective: To evaluate the use of recombinant activated factor VII (rFVIIa) in a patient with fulminant hepatic failure (FHF) requiring placement of an…”
Get full text
Journal Article -
11
Bortezomib-based antibody-mediated rejection therapy and simultaneous conversion to belatacept
Published in Transplantation (27-02-2014)Get full text
Report